Typhoid Fever Symptoms Causes Diagnosis Treatment and Prevention Guide

By: | Category: medicine | Views: 20

Typhoid fever (also called enteric fever) is a serious, systemic bacterial infection that primarily affects the intestines and bloodstream. It is caused by the gram-negative bacterium Salmonella enterica serovar Typhi (S. Typhi), a human-specific pathogen. If left untreated or inadequately treated, it can lead to severe complications and even death. It is distinct from the more common food poisoning caused by other Salmonella species and from paratyphoid fever (a similar but usually milder illness caused by S. Paratyphi A, B, or C).
Typhoid remains a major public health challenge in many developing regions, particularly in parts of South Asia (including India), Southeast Asia, Africa, and Latin America, where poor sanitation and contaminated water sources facilitate its spread. As of 2019 estimates from the World Health Organization (WHO), approximately 9 million people worldwide contract typhoid fever each year, resulting in about 110,000 deaths. In India and neighboring countries like Pakistan and Bangladesh, the burden is especially high due to dense populations, variable water quality, and increasing antibiotic resistance. In the United States and other developed countries, cases are rare (about 5,700 estimated illnesses annually in the US, mostly among international travelers), but global travel keeps the risk relevant.
Causes and Pathophysiology
The disease begins when a person ingests S. Typhi bacteria, typically through contaminated food or water. The bacteria are highly adapted to humans—they do not live in animals or the environment independently. Once swallowed, they survive the acidic stomach environment (especially in people with reduced stomach acid, such as those on antacids or with certain medical conditions) and invade the small intestine.
They enter through specialized cells (M cells) overlying Peyer's patches (lymphoid tissue in the gut wall). From there, the bacteria are taken up by macrophages and spread via the bloodstream in a process called primary bacteremia. They then multiply in the reticuloendothelial system (spleen, liver, bone marrow, and lymph nodes), leading to a secondary bacteremia that triggers the characteristic symptoms. The Vi capsule on S. Typhi helps it evade the immune system. Endotoxins released by the bacteria cause widespread inflammation, fever, and organ involvement. The bacteria can also colonize the gallbladder, leading to chronic carriage in some people.
Antibiotic resistance is a growing crisis: multidrug-resistant (MDR) strains, fluoroquinolone-non-susceptible (FQNS) strains, and extensively drug-resistant (XDR) strains (first prominent in Pakistan and now spreading elsewhere) complicate treatment and increase the risk of severe outcomes.
Transmission
Typhoid spreads via the fecal-oral route. Infected individuals (symptomatic or asymptomatic carriers) shed the bacteria in their stool (and sometimes urine). The bacteria contaminate:

Drinking water (untreated or mixed with sewage)
Food (especially raw vegetables, fruits that can't be peeled, salads, or street food handled by infected people)
Ice, unpasteurized milk, or juices
Surfaces touched by unwashed hands after using the bathroom

A famous historical example is "Typhoid Mary" (Mary Mallon), an asymptomatic carrier in early 20th-century New York who unknowingly infected dozens through her work as a cook. Chronic carriers (about 1–4% of recovered patients) can shed bacteria for over a year (sometimes lifelong), often due to gallstones harboring the bacteria in the gallbladder. Direct person-to-person spread is rare without poor hygiene.
Incubation Period and Symptoms
The incubation period is typically 6–30 days (average 1–3 weeks), depending on the infectious dose and host factors. Symptoms develop gradually and progress in stages if untreated:
Week 1 (Stage 1 – Invasion and bacteremia):
Low-grade fever that rises stepwise each day (often reaching 39–40°C / 102–104°F by week's end, highest in the evening). Other early symptoms include headache, fatigue, malaise, loss of appetite, chills, muscle aches, dry cough, and mild abdominal discomfort. Constipation is more common than diarrhea initially.
Week 2 (Stage 2 – Multiplication in lymphoid tissue):
Sustained high fever, severe weakness, abdominal pain and distension, diarrhea or persistent constipation, nausea, vomiting, and possible "rose spots" (faint pink maculopapular rash on the chest, abdomen, or back—present in <25% of cases, more visible on lighter skin). Hepatosplenomegaly (enlarged liver and spleen) may occur. Relative bradycardia (slow pulse despite high fever) is a classic but not universal sign.
Week 3 (Stage 3 – Severe disease, if untreated):
Persistent high fever with delirium, confusion ("typhoid state"), or stupor. Severe intestinal complications can emerge here.
Week 4 (Stage 4 – Resolution or complications):
If the immune system or treatment prevails, fever gradually subsides. Without treatment, the disease can last 3–4 weeks or longer, with a mortality rate historically as high as 10–20% (now 1–4% with prompt antibiotics, but higher in resistant cases or resource-limited settings).
Children often have milder or atypical presentations (more diarrhea/vomiting), while adults and the elderly may experience more severe systemic symptoms. In endemic areas like Gujarat, India, many locals develop partial immunity from repeated low-level exposure, leading to milder cases.
Diagnosis
Diagnosis relies on clinical suspicion (prolonged fever + travel/endemic exposure), supported by lab tests. Blood culture is the gold standard (positive in 50–70% of cases, highest in the first week). Bone marrow culture is more sensitive but invasive. Stool, urine, or rose-spot biopsies can also yield the bacteria. Serologic tests like the Widal test are widely used in developing countries but have poor specificity. Newer rapid antigen tests and PCR are emerging but not universally available. Other findings: leukopenia (low white blood cells), mild anemia, elevated liver enzymes, and thrombocytopenia.
Differential diagnosis includes malaria, dengue, brucellosis, tuberculosis, and other enteric infections.
Treatment
Prompt antibiotics are essential. Choice depends on local resistance patterns:

In areas with low resistance: Fluoroquinolones (e.g., ciprofloxacin) for 7–10 days.
In high-resistance areas (most of South Asia): Azithromycin (oral) for mild cases or ceftriaxone (IV) for severe/hospitalized cases.
XDR strains: Meropenem or other carbapenems; azithromycin combinations sometimes used.

Supportive care includes hydration, nutrition, fever management (acetaminophen), and hospital monitoring for complications. Steroids may be added for severe encephalopathy or shock. Treatment duration is typically 7–14 days; full recovery takes 1–2 weeks after starting effective therapy. Relapse occurs in up to 10% of cases (usually milder) 1–3 weeks later.
Chronic carriers may require prolonged antibiotics or cholecystectomy (gallbladder removal).
Complications
Occur in 10–15% of hospitalized cases, usually in weeks 2–3:

Intestinal perforation and peritonitis (life-threatening, higher mortality in Africa)
Intestinal bleeding
Encephalopathy, meningitis, or seizures
Myocarditis, pneumonia, or abscesses
Gallbladder inflammation, hepatitis, or osteomyelitis
Sepsis and multi-organ failure

Case-fatality ratio is about 0.9% in Asia but higher (around 5%) in parts of Africa with delayed care. Long-term, survivors may face relapse or chronic carriage (increasing risk of gallbladder cancer).
Prevention
Vaccination is highly recommended for travelers to endemic areas and residents in high-burden regions:

Typhoid conjugate vaccine (TCV): Single injectable dose for children ≥6 months and adults; longer-lasting immunity; being rolled out in childhood programs in countries like India, Pakistan.
Older vaccines: Injectable Vi polysaccharide (ages ≥2) or oral live attenuated (ages ≥6).

Vaccines are 50–80% effective and do not replace hygiene practices.
Key behavioral prevention (the "5 keys to safer food" from WHO):

Wash hands frequently with soap.
Drink only boiled, bottled, or treated water; avoid ice.
Eat thoroughly cooked hot foods; avoid raw salads or unpeeled fruits.
Practice safe food handling and sanitation.
Ensure proper sewage disposal and clean water access at community level.

In India, government programs promote TCV, improved WASH (water, sanitation, hygiene), and awareness, especially in urban slums or rural areas.
Prognosis and Living with Typhoid
With early diagnosis and appropriate antibiotics, most people recover fully within 1–2 weeks, with <1–2% fatality in treated cases. Without treatment, the illness drags on for weeks and carries high risk of death or lifelong complications. Recovered patients should complete antibiotics, practice strict hygiene (especially food handlers), and get follow-up testing to confirm they are no longer carriers. Return to normal activities is usually possible once fever-free and cleared by a doctor.
In summary, typhoid fever is a preventable yet persistent threat in areas like Ahmedabad and much of India, driven by sanitation gaps and evolving bacterial resistance. Awareness, vaccination, safe water/food practices, and rapid medical care are the best defenses. If you or someone you know has prolonged fever, especially after travel or in an endemic area, seek medical attention immediately—early treatment saves lives. For personalized advice, consult a healthcare professional or local public health resources (e.g., in Gujarat, through government hospitals or CDC/WHO travel guidelines).
This description is based on current data from authoritative sources including WHO, CDC, Mayo Clinic, Cleveland Clinic, and medical literature (as of 2023–2025 updates). Medical information evolves, so always verify with recent guidelines.